San Francisco-based Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Founded by Melanie Matheu and Noelle Mullin in 2016, Prellis Biologics is backed by investors that include Cantos, IndieBio, Plug and Play, SOSV, and True Ventures.